Groesbeck Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$436K Sell
3,396
-76
-2% -$8.9K 0.69% 35
2026
Q1
$418K Hold
3,472
0.81% 36
2025
Q4
$365K Sell
3,472
-1,488
-30% -$140K 0.69% 38
2025
Q3
$416K Sell
4,960
-2,698
-35% -$222K 0.81% 37
2025
Q2
$606K Sell
7,658
-763
-9% -$60.6K 1.06% 31
2025
Q1
$756K Sell
8,421
-814
-9% -$76K 1.06% 33
2024
Q4
$919K Buy
9,235
+1,755
+23% +$181K 1.2% 25
2024
Q3
$849K Sell
7,480
-1,098
-13% -$130K 1.25% 26
2024
Q2
$1.06M Sell
8,578
-162
-2% -$20.9K 1.47% 21
2024
Q1
$1.15M Buy
8,740
+417
+5% +$51.4K 1.23% 24
2023
Q4
$907K Buy
8,323
+780
+10% +$81K 1.26% 28
2023
Q3
$777K Buy
7,543
+1,343
+22% +$145K 1.18% 29
2023
Q2
$715K Sell
6,200
-1,141
-16% -$130K 1.09% 32
2023
Q1
$781K Buy
7,341
+145
+2% +$15.7K 1.17% 29
2022
Q4
$798K Buy
7,196
+150
+2% +$15.3K 1.34% 27
2022
Q3
$642K Hold
7,046
1.06% 33
2022
Q2
$642K Sell
7,046
-216
-3% -$19.1K 1.06% 33
2022
Q1
$596K Buy
7,262
+57
+0.8% +$4.49K 0.67% 56
2021
Q4
$552K Sell
7,205
-123
-2% -$9.8K 0.7% 50
2021
Q3
$550K Sell
7,328
-1,191
-14% -$90.6K 0.64% 60
2021
Q2
$663K Buy
8,519
+618
+8% +$46K 0.84% 46
2021
Q1
$581K Buy
7,901
+6
+0.1% +$443 0.84% 46
2020
Q4
$616K Buy
7,895
+44
+0.6% +$3.37K 1.01% 38
2020
Q3
$621K Buy
7,851
+7
+0.1% +$548 1.16% 31
2020
Q2
$579K Buy
+7,844
New +$591K 1.15% 37

Other funds holding MRK

Groesbeck Investment Management's MRK Position: Q2 2026 in Review

Groesbeck Investment Management reduced its Merck (MRK) stake by 2.2% in Q2 2026, selling an estimated $8.9K and leaving 3,396 shares worth $436K. The position accounts for 0.69% of the portfolio, ranked #35.

Groesbeck Investment Management first reported a position in MRK in Q2 2020 and has held it in 25 quarters since. The position peaked at $1.15M in Q1 2024. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Groesbeck Investment Management held 3,396 shares of Merck worth $436K as of Q2 2026.
  • Groesbeck Investment Management sold 76 Merck shares in Q2 2026, an estimated $8.9K.
  • Merck made up 0.69% of Groesbeck Investment Management's portfolio in Q2 2026, its #35 holding.
  • Groesbeck Investment Management first reported a position in Merck in Q2 2020 and has held it in 25 quarters since.
  • Groesbeck Investment Management's Merck position peaked at $1.15M in Q1 2024.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Groesbeck Investment Management's 13F filing for Q2 2026, filed 15 Jul 2026.